SciELO - Scientific Electronic Library Online

 
vol.34 issue3Cardiovascular toxicity by rivastigmine transdermal patches. Two case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Related links

Share


Revista Uruguaya de Cardiología

Print version ISSN 0797-0048On-line version ISSN 1688-0420

Abstract

LOSS, Francisco Schossler; UEDA, Leandro Shigueru Ikuta  and  LUIZ, Alcirley de Almeida. Hypertrophic cardiomyopathy. Case report. Rev.Urug.Cardiol. [online]. 2019, vol.34, n.3, pp.184-196.  Epub Dec 01, 2019. ISSN 0797-0048.  https://doi.org/10.29277/cardio.34.3.16.

Hypertrophic cardiomyopathy is a common inherited disease, which occurs in 1 in 500 individuals and affects both sexes. It presents with left ventricular hypertrophy in the absence of another cardiac or systemic disease capable of producing an increase in the thickness of the left ventricle wall. The clinical manifestations of hypertrophic cardiomyopathy are varied, from asymptomatic left ventricular hypertrophy or progressive heart failure to sudden cardiac death. Common symptoms include dyspnea, chest pain, palpitations, pre-syncope and syncope. Most of the time, left ventricular hypertrophy is evident during adolescence or youth. We describe the case of a male patient of 43 years, who presented a hypertensive emergency without previous history of systemic arterial hypertension. Through complementary exams, hypertrophic middle-apical myocardiopathy was diagnosed without obstruction of the left ventricular outflow tract.

Keywords : Hypertrophic cardiomyopathy; Case reports; Sudden death.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )